(Q24234875)

Cochrane Database of Systematic Reviews

inferred from title

vulvovaginal candidiasis

1 reference

Amita Ray

1

Amita

Ray

1 reference

1 December 2023

Sujoy Ray

series ordinal

2

author given names

Sujoy

author last names

Ray

1 reference

1 December 2023

Aneesh Thomas George

series ordinal

3

author given names

Aneesh Thomas

author last names

George

1 reference

1 December 2023

Narasimman Swaminathan

series ordinal

4

author given names

Narasimman

author last names

Swaminathan

1 reference

1 December 2023

language of work or name

1 reference

10 August 2011

0 references

published in

0 references

cites work

Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial. Terry Beirn Community Programs for Clinical Research on AIDS.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Evaluation of two self-care treatments for prevention of vaginal candidiasis in women with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Bacterial vaginosis in female facility workers in north-western Tanzania: prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Etiology and determinants of sexually transmitted infections in Karnataka state, south India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

In vitro and in vivo anticandidal activity of human immunodeficiency virus protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Clinical pharmacokinetics of fluconazole in superficial and systemic mycoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Bacterial vaginosis, vaginal flora patterns and vaginal hygiene practices in patients presenting with vaginal discharge syndrome in The Gambia, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

SAVVY vaginal gel (C31G) for prevention of HIV infection: a randomized controlled trial in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Effectiveness of cellulose sulfate vaginal gel for the prevention of HIV infection: results of a Phase III trial in Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

The management of uncomplicated adult gonococcal infection: should test of cure still be routine in patients attending genitourinary medicine clinics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Lime juice as a candidate microbicide? An open-label safety trial of 10% and 20% lime juice used vaginally

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Intravaginal practices, vaginal infections and HIV acquisition: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Treatment of fungal infection in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Estradiol valerate/dienogest: in oral contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Prevalence of sexually transmitted diseases (STD) among women in a suburban Sudanese community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Fluconazole resistant non-albicans vaginal yeast in HIV seronegative women with vaginal discharge in Pune, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

New developments in medical mycology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Microbiological profile of the cervix in 1,000 sexually active women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Evaluation and management of HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Creating and validating an algorithm to measure AIDS mortality in the adult population using verbal autopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Intermittent antiretroviral therapy in patients with controlled HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Improvement of vaginal health for Kenyan women at risk for acquisition of human immunodeficiency virus type 1: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Prospective study of vaginal bacterial flora and other risk factors for vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Cervicovaginal cytological abnormalities in patients with human immunodeficiency virus infection, in relation to disease stage, CD4 cell count and viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Sexually transmitted infections among brothel-based sex workers in bangladesh: high prevalence of asymptomatic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Population-based assessment of Mycoplasma genitalium in Vietnam--low prevalence among married women of reproductive age in a rural area

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Urinary tract infection among asymptomatic HIV patients in Benin City, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

The syndromic management of vaginal discharge using single-dose treatments: a randomized controlled trial in West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Tenofovir disoproxil fumarate for prevention of HIV infection in women: a phase 2, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Efficacy and safety of vitamin C vaginal tablets in the treatment of non-specific vaginitis. A randomised, double blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Aetiology of sexually transmitted infections and response to syndromic treatment in southwest Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Opportunistic candidal infections in patients infected with human immunodeficiency virus: prevention issues and priorities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Treatment options for vulvovaginal candidiasis, 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

AIDS in pregnancy, part II: Treatment in the era of highly active antiretroviral therapy and management of obstetric, anesthetic, and pediatric issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Pharmacologic management of sexually transmitted diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Medicinal plants used by Tanzanian traditional healers in the management of Candida infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Asymptomatic bacterial vaginosis: response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Symptomatic vulvovaginitis due to fluconazole-resistant Candida albicans in a female who was not infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Quality of sexually transmitted disease treatments in the formal and informal sectors of Bangui, Central African Republic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Intermittent intravaginal antibiotic treatment of bacterial vaginosis in HIV-uninfected and -infected women: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Safety and efficacy of saquinavir soft-gelatin capsules + zidovudine + optional lamivudine in pregnancy and prevention of vertical HIV transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Vaginal yeasts in the era of "over the counter" antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Nonoxynol-9 in lubricated condoms. Results of a study in female prostitutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Systemic antifungal agents. Drug interactions of clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Metabolism of amprenavir in liver microsomes: role of CYP3A4 inhibition for drug interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Probiotics for prevention of recurrent vulvovaginal candidiasis: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Incidence of opportunistic and other infections in HIV-infected children in the HAART era.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Efficacy of maintenance therapy with topical boric acid in comparison with oral itraconazole in the treatment of recurrent vulvovaginal candidiasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Vaginal infections in human immunodeficiency virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Pharmacokinetics of didanosine and ketoconazole after coadministration to patients seropositive for the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Candida glabrata: an emerging oral opportunistic pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Resistance of Candida species to fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Determinants of incident vulvovaginal candidiasis in human immunodeficiency virus-positive women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Evolutionary dynamics of complex networks of HIV drug-resistant strains: the case of San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Treatment of vaginal Candida infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Esophageal candidiasis in AIDS. Successful therapy with clotrimazole vaginal tablets taken by mouth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Her choice: dealing with lactobacilli, vaginitis, and antibiotics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Treatment of fungal skin infections: state of the art.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Human immunodeficiency virus infection in women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Triazole therapy for mucocutaneous candidiasis in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Prevalence and exoenzyme secretion by Candida albicans isolates from oral and vaginal mucosas of HIV-infected women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Evolution of antifungal susceptibility among Candida species isolates recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Evaluation of a low-dose nonoxynol-9 gel for the prevention of sexually transmitted diseases: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

HIV-1 natural viral suppressors: control of viral replication in the absence of therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

High aspartyl proteinase production and vaginitis in human immunodeficiency virus-infected women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Frequency and significance of drug resistance in vulvovaginal candidiasis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Prevention of recurrent vaginal candidiasis with weekly terconazole cream

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Vulvovaginal candidiasis: a comparison of HIV-positive and -negative women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021

Acceptability of a novel vaginal microbicide during a safety trial among low-risk women

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008739.PUB2

7 January 2021